Cycloleucine blocks NMDA responses in cultured hippocampal neurones under voltage clamp

Antagonism at the strychnine-insensitive glycine receptor.

N. Hershkowitz, Michael A Rogawski

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Radioligand binding studies have demonstrated that the neutral amino acid cycloleucine may act as a competitive antagonist at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. In the present study, we examined the effects of cycloleucine on NMDA-evoked inward current responses in dissociated hippocampal neuronal cultures using the whole cell voltage-clamp technique. In the presence of 1 μ glycine, cycloleucine caused a reversible, dose-dependent inhibition of NMDA responses with an IC50 of 24 μM. An increase in glycine to 100 μM resulted in a shift to the right of the cycloleucine concentration-effect curve (IC50, 1.4 mM). However, with cycloleucine concentrations ≤ 100 μM, a fraction of the block could not be overcome by glycine even at concentrations as high as 1 mM. The cycloleucine block was unaffected by shifts in the holding potential (-60 to +60 mV), and there was no effect of cycloleucine on the reversal potential of the NMDA-evoked current. Cycloleucine failed to effect kainic acid- and quisqualic acid-evoked currents at concentrations which inhibited NMDA responses. We conclude that cycloleucine is a potent and selective antagonist of NMDA-receptor mediated responses. Although this effect occurs in part via competitive antagonism at the glycine modulatory site, the cyloleucine block cannot be completely reversed by glycine indicating an interaction with an additional site on the receptor-channel complex.

Original languageEnglish (US)
Pages (from-to)1005-1013
Number of pages9
JournalBritish Journal of Pharmacology
Volume98
Issue number3
StatePublished - 1989
Externally publishedYes

Fingerprint

Cycloleucine
N-Methylaspartate
Neurons
Glycine
N-Methyl-D-Aspartate Receptors
Inhibitory Concentration 50
Quisqualic Acid
Neutral Amino Acids
strychnine-insensitive glycine receptor
Kainic Acid
Patch-Clamp Techniques

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{e1078513f9f14cafbae9387a0718ac8d,
title = "Cycloleucine blocks NMDA responses in cultured hippocampal neurones under voltage clamp: Antagonism at the strychnine-insensitive glycine receptor.",
abstract = "Radioligand binding studies have demonstrated that the neutral amino acid cycloleucine may act as a competitive antagonist at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. In the present study, we examined the effects of cycloleucine on NMDA-evoked inward current responses in dissociated hippocampal neuronal cultures using the whole cell voltage-clamp technique. In the presence of 1 μ glycine, cycloleucine caused a reversible, dose-dependent inhibition of NMDA responses with an IC50 of 24 μM. An increase in glycine to 100 μM resulted in a shift to the right of the cycloleucine concentration-effect curve (IC50, 1.4 mM). However, with cycloleucine concentrations ≤ 100 μM, a fraction of the block could not be overcome by glycine even at concentrations as high as 1 mM. The cycloleucine block was unaffected by shifts in the holding potential (-60 to +60 mV), and there was no effect of cycloleucine on the reversal potential of the NMDA-evoked current. Cycloleucine failed to effect kainic acid- and quisqualic acid-evoked currents at concentrations which inhibited NMDA responses. We conclude that cycloleucine is a potent and selective antagonist of NMDA-receptor mediated responses. Although this effect occurs in part via competitive antagonism at the glycine modulatory site, the cyloleucine block cannot be completely reversed by glycine indicating an interaction with an additional site on the receptor-channel complex.",
author = "N. Hershkowitz and Rogawski, {Michael A}",
year = "1989",
language = "English (US)",
volume = "98",
pages = "1005--1013",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Cycloleucine blocks NMDA responses in cultured hippocampal neurones under voltage clamp

T2 - Antagonism at the strychnine-insensitive glycine receptor.

AU - Hershkowitz, N.

AU - Rogawski, Michael A

PY - 1989

Y1 - 1989

N2 - Radioligand binding studies have demonstrated that the neutral amino acid cycloleucine may act as a competitive antagonist at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. In the present study, we examined the effects of cycloleucine on NMDA-evoked inward current responses in dissociated hippocampal neuronal cultures using the whole cell voltage-clamp technique. In the presence of 1 μ glycine, cycloleucine caused a reversible, dose-dependent inhibition of NMDA responses with an IC50 of 24 μM. An increase in glycine to 100 μM resulted in a shift to the right of the cycloleucine concentration-effect curve (IC50, 1.4 mM). However, with cycloleucine concentrations ≤ 100 μM, a fraction of the block could not be overcome by glycine even at concentrations as high as 1 mM. The cycloleucine block was unaffected by shifts in the holding potential (-60 to +60 mV), and there was no effect of cycloleucine on the reversal potential of the NMDA-evoked current. Cycloleucine failed to effect kainic acid- and quisqualic acid-evoked currents at concentrations which inhibited NMDA responses. We conclude that cycloleucine is a potent and selective antagonist of NMDA-receptor mediated responses. Although this effect occurs in part via competitive antagonism at the glycine modulatory site, the cyloleucine block cannot be completely reversed by glycine indicating an interaction with an additional site on the receptor-channel complex.

AB - Radioligand binding studies have demonstrated that the neutral amino acid cycloleucine may act as a competitive antagonist at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. In the present study, we examined the effects of cycloleucine on NMDA-evoked inward current responses in dissociated hippocampal neuronal cultures using the whole cell voltage-clamp technique. In the presence of 1 μ glycine, cycloleucine caused a reversible, dose-dependent inhibition of NMDA responses with an IC50 of 24 μM. An increase in glycine to 100 μM resulted in a shift to the right of the cycloleucine concentration-effect curve (IC50, 1.4 mM). However, with cycloleucine concentrations ≤ 100 μM, a fraction of the block could not be overcome by glycine even at concentrations as high as 1 mM. The cycloleucine block was unaffected by shifts in the holding potential (-60 to +60 mV), and there was no effect of cycloleucine on the reversal potential of the NMDA-evoked current. Cycloleucine failed to effect kainic acid- and quisqualic acid-evoked currents at concentrations which inhibited NMDA responses. We conclude that cycloleucine is a potent and selective antagonist of NMDA-receptor mediated responses. Although this effect occurs in part via competitive antagonism at the glycine modulatory site, the cyloleucine block cannot be completely reversed by glycine indicating an interaction with an additional site on the receptor-channel complex.

UR - http://www.scopus.com/inward/record.url?scp=0024454019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024454019&partnerID=8YFLogxK

M3 - Article

VL - 98

SP - 1005

EP - 1013

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 3

ER -